Literature DB >> 7622105

Endometrial carcinoma in elderly women.

K Hoffman1, L Nekhlyudov, L Deligdisch.   

Abstract

Endometrial carcinoma remains the most common invasive gynecologic malignancy. Increased longevity is associated with an increased incidence of endometrial carcinoma (EC) in elderly women. While recent studies have looked at aging and its relation to ovarian, breast, and cervical cancer, few have focused on EC in the growing elderly population. This study analyzed 35 histologic specimens of EC in women 75-92 years of age. Findings revealed that only 23% of the tumors were Stage I, G1. The majority (77%) were deeply invasive or of advanced stage (IC-IV). These were G2, G3, or "virulent" types of nonendometrioid EC (undifferentiated, clear cell, uterine serous papillary, and squamous cell carcinoma). Fifty-seven percent of tumors were endometrioid, of which 9% were mixed, including a rare case of nongestational choriocarcinoma. The nonendometrioid tumors, compared to the endometrioid types, were more often high-stage tumors with vascular invasion. They were also more often associated with atrophic (vs hyperplastic) uninvolved endometrium. Clinical risk factors (nulliparity, obesity, estrogen replacement therapy) were assessed and correlated with the histologic findings. It was shown that tumors in the elderly were less likely to be estrogen-related. It was concluded that EC in this age group is more aggressive, histologically less differentiated, and often nonendometrioid compared with EC in the general population. The increased virulence of EC in the elderly may be related to the tumor's independence from hormonal factors, to the poorly understood but well-known diminished immunologic defense against cancer in general in elderly patients, and/or to the belated diagnosis of the disease in this population.

Entities:  

Mesh:

Year:  1995        PMID: 7622105     DOI: 10.1006/gyno.1995.1210

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.

Authors:  Ashley S Felix; D Scott McMeekin; David Mutch; Joan L Walker; William T Creasman; David E Cohn; Shamshad Ali; Richard G Moore; Levi S Downs; Olga B Ioffe; Kay J Park; Mark E Sherman; Louise A Brinton
Journal:  Gynecol Oncol       Date:  2015-09-01       Impact factor: 5.482

2.  Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria.

Authors:  Tae Wook Kong; Suk Joon Chang; Jiheum Paek; Yonghee Lee; Mison Chun; Hee Sug Ryu
Journal:  J Gynecol Oncol       Date:  2014-11-03       Impact factor: 4.401

3.  Effects of surgery on survival of patients aged 75 years or older with oral tongue squamous cell carcinomas.

Authors:  Yujiao Li; Chu Chu; Chaosu Hu
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

4.  Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer.

Authors:  M Fairuz B Jamaluddin; Yi-An Ko; Arnab Ghosh; Shafiq M Syed; Yvette Ius; Rachel O'Sullivan; Jacob K Netherton; Mark A Baker; Pravin Nahar; Kenneth Jaaback; Pradeep S Tanwar
Journal:  Cell Rep Med       Date:  2022-09-13

5.  The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus.

Authors:  Marzieh Vahid Dastjerdi; Soraya Ahmari; Sadaf Alipour; Afsaneh Tehranian
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-07-01

6.  First-stage clear-cell endometrial carcinoma with paraaortic lymph node recurrence: a case report.

Authors:  Strahil Asenov Strashilov; Stanislav Slavchev; Stoyan Kostov; Angel Yordanov
Journal:  Prz Menopauzalny       Date:  2021-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.